Here's why Capitol Health Ltd shares are being annihilated today

Capitol Health Ltd (ASX:CAJ) shares got smashed today after announcing its full year results. Is this one healthcare share you should avoid?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shareholders of diagnostic imaging company Capitol Health Ltd (ASX: CAJ) may be suffering from a spot of déjà vu today after the announcement of disappointing preliminary full year results and the suspension of its final dividend sent its share price lower by as much as 20%.

This was a similar story to six months ago when a sell off ensued following the company reporting a 19% drop in profits and suspension of its interim dividend.

Unfortunately for investors that expected things to improve as the year went on, things very much went the other way. Although revenue is expected to be up by 42% on FY 2015 to $158 million, on the bottom line the company expects to make a net loss before tax of $3.2 million.

Management revealed that this result was impacted by impairment charges, one-off acquisition costs, and restructuring costs amounting to $13 million.

This will be a second consecutive year of declining profits, which is no doubt very worrying for shareholders considering its $103 million debt. With its cash balance standing at $16 million I do have concerns that there could be some capital raising for Capitol Health around the corner.

As well as announcing its preliminary financial results, Capitol Health also used the announcement to advise that chief operating officer Peter Lewis will be stepping down after 12 months with the company. Whilst the company hasn't provided a reason for his departure, it doesn't fill me with a great deal of confidence to learn that a key member of the c-suite is leaving after such a short period of time with the company.

Managing Director John Conidi had this to say on the results:

"While this financial year has been difficult for the industry, Capitol has revenue growth and EBITDA consistency with the prior corresponding period. The outlook remains challenging to predict but we remain cautiously optimistic and are confident that the transformative nature of the investments we have made across the last two financial years coupled with our continuing investment in technology will drive earnings in FY17 and beyond."

Despite how cheap Capitol Health's shares may look now, I wouldn't suggest buying the dip. Its declining profits and potential for a capital raising could well take the share price even lower in the coming months in my opinion.

Instead I feel investors would be better served taking a closer look at other healthcare shares such as Ramsay Health Care Limited (ASX: RHC), REVA Medical Inc (ASX: RVA), Pro Medicus Limited (ASX: PME) and Australian Pharmaceutical Industries Ltd (ASX: API).

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »